Evidence map›Paper›PMID 38517388›Full record

ArticleAging2024

Evaluation of the clinical significance of long non-coding RNA

Shu-Hui Lin, Jeng-Wei Lu, Wang-Ting Hsieh, Ying-Erh Chou, Tzu-Cheng Su, Tun-Jen Tsai, Yun-Jung Tsai, Po-Jen Yang, Shun-Fa Yang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Shu-Hui LinDepartment of Pathology, Changhua Christian Hospital, Changhua, Taiwan.
Jeng-Wei LuBiotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Wang-Ting HsiehThe Affiliated High School of Tunghai University, Taichung, Taiwan.
Ying-Erh ChouSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Tzu-Cheng SuDepartment of Pathology, Changhua Christian Hospital, Changhua, Taiwan.
Tun-Jen TsaiThe Affiliated High School of Tunghai University, Taichung, Taiwan.
Yun-Jung TsaiTranslational Pathology Core Laboratory, Changhua Christian Hospital, Changhua, Taiwan.
Po-Jen YangSchool of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Shun-Fa YangInstitute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Chung Shan Medical University · TWChanghua Christian Hospital · TWAsia University · TWNational Chung Hsing University · TWRigshospitalet · DKTunghai University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung adenocarcinoma (LUAD) is the most frequent histological subtype of lung cancer, which is the most common malignant tumor and the main cause of cancer-related mortality globally. Recent reports revealed that long non-coding RNA (lncRNA) of metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) plays a crucial role in tumorigenesis and metastasis development in lung cancer. However, the contribution of

Indexed as

AdenocarcinomaLung NeoplasmsRNA, Long NoncodingClinical RelevanceErbB ReceptorsGenetic Predisposition to DiseaseHumansLungPolymorphism, Single NucleotideErbB ReceptorsMALAT1 long non-coding RNA, humanRNA, Long NoncodingEGFRlung adenocarcinomaMALAT1single nucleotide polymorphism

Identifiers

PMID38517388
PMCPMC11006483
OpenAlexW4393041014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.